Mahamaya Lifesciences Ltd vs Upl Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Mahamaya Lifesciences Ltd is ₹ 190.1 as of 05 May 15:30 . The P/E Ratio of Mahamaya Lifesciences Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of UPL Ltd changed from 17.1 on March 2021 to 56.4 on March 2025 . This represents a CAGR of 26.96% over 5 years The Market Cap of Mahamaya Lifesciences Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of UPL Ltd changed from ₹ 49067 crore on March 2021 to ₹ 51826 crore on March 2025 . This represents a CAGR of 1.10% over 5 years The revenue of Mahamaya Lifesciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of UPL Ltd for the Dec '25 is ₹ 12361 crore as compare to the Sep '25 revenue of ₹ 12411 crore. This represent the decline of -0.4% The ebitda of Mahamaya Lifesciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of UPL Ltd for the Dec '25 is ₹ 2272 crore as compare to the Sep '25 ebitda of ₹ 2339 crore. This represent the decline of -2.86% The net profit of Mahamaya Lifesciences Ltd changed from ₹ 5.53 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The net profit of UPL Ltd changed from ₹ -527 crore to ₹ 490 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Mahamaya Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of UPL Ltd changed from 347.73 % on March 2021 to 16.23 % on March 2025 . This represents a CAGR of -45.82% over 5 years .

About Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as 'Mahamaya Life Sciences Private Limited' by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002.
Further, Company's name was changed from 'Mahamaya Life Sciences Private Limited' to 'Mahamaya Lifesciences Private Limited' dated February 15, 2016.
The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre. The Company specializes in manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs).
The Company began the journey by focusing on import and registration of vital pesticide molecules.
It imported these molecules and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India.

About UPL Ltd

UPL Limited was initially incorporated as 'Vishwanath Commercials Limited' on January 2, 1985.
The Company name was changed from Vishwanath Commercials Limited to Search Chem Industries Limited on 24 February, 1985.
Again, the name of the Company was changed from Search Chem Industries Limited to United Phosphorus Limited on 30 September, 2013 and subsequently was changed to UPL Limited from United Phosphorus Limited on 23 October, 2013. UPL Limited is a global generic crop protection, chemicals and seeds company.
The Company is engaged in the agro-business of production and sale of agrochemicals, field crops, vegetable seeds and non-agro business of production and sale of industrial chemicals, chemical intermediates & speciality chemicals.
They operate in three segments: agro chemical, industrial chemicals and others.

FAQs for the comparison of Mahamaya Lifesciences Ltd and UPL Ltd

Which company has a larger market capitalization, Mahamaya Lifesciences Ltd or UPL Ltd?

Market cap of Mahamaya Lifesciences Ltd is 444 Cr while Market cap of UPL Ltd is 54,212 Cr

What are the key factors driving the stock performance of Mahamaya Lifesciences Ltd and UPL Ltd?

The stock performance of Mahamaya Lifesciences Ltd and UPL Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mahamaya Lifesciences Ltd and UPL Ltd?

As of May 5, 2026, the Mahamaya Lifesciences Ltd stock price is INR ₹190.1. On the other hand, UPL Ltd stock price is INR ₹642.4.

How do dividend payouts of Mahamaya Lifesciences Ltd and UPL Ltd compare?

To compare the dividend payouts of Mahamaya Lifesciences Ltd and UPL Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.